SCHEMBL2854876

SCHEMBL2854876

c1ccc(-n2c(-c3ccc(-c4c5ccccc5c(-c5ccc6ccc7ccccc7c6c5)c5ccccc45)cc3)nc3ccccc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.51
ESR2 Q92731 1/20 0.51
GRIA1 P42261 1/20 0.47
CACNG8 Q8WXS5 1/20 0.47
CACNG2 Q9Y698 1/20 0.47
PTGER4 P35408 1/20 0.46
HTT P42858 2/20 0.44
MAPK1 P28482 1/20 0.44
PTGS2 P35354 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
HSP90AA1 P07900 1/20 0.42
MAPT P10636 1/20 0.42
RECQL P46063 1/20 0.42
ALDH1A1 P00352 7/20 0.42
SIRT2 Q8IXJ6 2/20 0.42
SIRT1 Q96EB6 2/20 0.42
PRKACA P17612 1/20 0.41
RPS6KB1 P23443 1/20 0.41
GSK3B P49841 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9612439 0.94 ESR1 (0.48) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL13015708 0.93 ESR1 (0.45) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL13015698 0.93 ESR1 (0.45) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL27012986 0.93 ESR1 (0.51) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12144452 0.92 ESR1 (0.48) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL26825359 0.91 ESR1 (0.50) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL134057 0.91 ESR1 (0.52) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL18999492 0.91 PTGER4 (0.47) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL29444817 0.91 ESR1 (0.52) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL13098744 0.91 ESR1 (0.52) ESR1ESR2GRIA1CACNG8CACNG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8993123-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-03-31 US disclosed
US-8993123-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-03-31 US disclosed
US-8993123-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-03-31 US disclosed
US-20100327270-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-12-30 US disclosed
US-20100327270-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-12-30 US disclosed
US-20100327270-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-12-30 US disclosed
EP-2240425-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2010-10-20 EP disclosed
WO-2009100925-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2009-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327270-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, ELAVL1, EPCAM ESR1 387/4885ESR2 320/4885GRIA1 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.